BrightGene Bio-Medical Technology Co., Ltd.

Business Type:Manufacturer

Main Products:Caspofungin/Micafungin/Anidulafungin,Everolimus,Maytansinol/Ansamitocin P3,Posaconazole,Entecavir,Fondaparinux,Dalbavancin/Oritavancin,DM1/DM4,Fidaxomicin

Country/Region:China

Year Established:2001

Ddu Verified

HOT Rank

8/10
Leave a message
Company Information

BrightGene is R&D driving company, focus on niche specialty generics, with high-tech barrier, such as fermentation and multi-chiral.

we support our customer P4 patent challenge with non-infringing process and polymorph 

our manufacturing sites have been approved by FDA EDQM PMDA KFDA and CFDA.

main products are anti-fungin, HBV, antibiotics, Cardiovascular.

Email to this supplier
To

Send

Inquiry Cart(0)